Primerica, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated August 7, 2019, reports the results of operations for Primerica, Inc. for the quarter ended June 30, 2019. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1) and supplemental financial information (Exhibit 99.2), which are referenced but not included in the provided text.
The Company reports both GAAP and non-GAAP financial measures. Key non-GAAP metrics defined in the filing include:
- Adjusted direct premiums and other ceded premiums (net of IPO coinsurance transactions).
- Adjusted operating revenues, income before taxes, and net operating income (excluding realized investment gains/losses and fair value mark-to-market adjustments).
- Diluted adjusted operating earnings per share.
- Adjusted stockholders' equity (excluding net unrealized investment gains/losses).
Material Changes and Comparisons
The filing text does not contain specific data regarding material changes versus the prior comparable period. It notes that amounts ceded under IPO coinsurance transactions will continue to decline over time as policies terminate, which impacts the adjusted premium metrics.
Guidance, Outlook, and Management Commentary
Management utilizes non-GAAP measures to evaluate performance and eliminate period-over-period fluctuations caused by investment timing and market pricing variations. The filing states that these measures are intended to reflect core ongoing business operations. No specific forward-looking guidance or outlook numbers are provided in the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2019 GAAP and non-GAAP financial results.
- Examine Exhibit 99.2 for supplemental financial information and reconciliations of GAAP to non-GAAP measures.
- Verify the impact of the declining IPO coinsurance transactions on adjusted premium figures.
- Confirm the treatment of realized investment gains/losses and mark-to-market adjustments in the reported non-GAAP income.